Company intelligence / Profile preview

Premise Data

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Premise is not a therapeutics company and has no drug-development or clinical pipeline; it operates a global, crowdsourced data-collection and analytics platform used across sectors including international development and global health monitoring.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

United Nations agencies (e.g., FAO)World BankBill & Melinda Gates FoundationGavi, the Vaccine AllianceUSAID and implementing partners such as iMMAPVarious international development and humanitarian organizations

Beyond the preview

Go deeper on Premise Data.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Premise Data.

Explore the full profile